Rhenman & Partners Asset Management AB reduced its position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 65.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,000 shares of the company’s stock after selling 25,000 shares during the […]